US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.84

-0.1300-0.72%

Post-market: 17.840.00000.00%19:30 EDT

Volume:33.44K

Turnover:596.90K

Market Cap:105.26M

PE:- -

High:18.01

Open:17.97

Low:17.75

Close:17.97

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:0.64

T/O Rate:0.57%

Dividend:0.71

Dividend Rate:4.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

JPMorgan Highlights Strong Overall Survival Data from Akeso's HARMONi-2 Trial, Reaffirms Overweight Rating

Big Pharma is Pouring Billions into China's Biotechs

Innovent's Enlarged Cash Holdings, Investment Fair Value Could Boost Earnings

Citi Highlights Akeso's HARMONi-2 Overall Survival Edge, Reaffirming Buy Rating on Differentiation

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Hong Kong Market Update | CRO Stocks Lead Gains as Interim Results Reinforce Sector Momentum, Multiple Firms Lift Guidance

AKESO Shares Climb After WCLC Data Highlights OS Benefit of Lead Drug Versus Keytruda

Goldman Sachs Sees Clear Recovery in China's CRO/CDMO Sector, Favorable on WuXi-Linked Stocks

Akeso Says Phase III HARMONi-2 Trial Shows Ivonescimab Lifts Overall Survival vs Pembrolizumab in PD-L1-Positive NSCLC

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Global Equities Roundup: Market Talk

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

WuXi Biologics Files HKEX Next-Day Disclosure, Share Capital Rises by 1.2 Million Shares

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/KURE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.84,"timestamp":1789588800000,"preClose":17.97,"halted":0,"volume":33439,"hourTrading":{"tag":"盘后","latestPrice":17.84,"preClose":17.84,"latestTime":"19:30 EDT","volume":8,"amount":142.72,"timestamp":1789601403520,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007234279354479634,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Not Yet Opened","change":-0.13,"latestTime":"09-16 16:00:00 EDT","open":17.97,"high":18.01,"low":17.75,"amount":596901.030355,"amplitude":0.014469,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.97,"sharesOutstanding":4750002,"nav":18.07,"aum":106625710.77,"dividendRate":0.040067,"bidAskSpread":0.007897,"postHourTrading":{"tag":"盘后","latestPrice":17.84,"preClose":17.84,"latestTime":"19:30 EDT","volume":8,"amount":142.72,"timestamp":1789601403520,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.641521,"impliedVol":0.2936,"impliedVolPercentile":0.628},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.641521,"shares":5900168,"dividePrice":0.7148,"high":18.01,"amplitude":0.014469,"preClose":17.97,"low":17.75,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":17.84,"eps":0,"divideRate":0.040067,"volume":33439,"delay":0,"ttmEps":0,"open":17.97,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.15,"twentyDayClose":18.7299,"sixtyDayClose":14.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1160507484","title":"JPMorgan Highlights Strong Overall Survival Data from Akeso's HARMONi-2 Trial, Reaffirms Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1160507484","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160507484?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:14","pubTimestamp":1789373662,"startTime":"0","endTime":"0","summary":"JPMorgan has released a research report following Akeso's (09926) updated overall survival (OS) data from its HARMONi-2 trial, noting that the results are notably robust. The hazard ratio (HR) stands...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU2237443465.HKD","LU2456880835.USD","LU0971096721.USD","LU1244550494.USD","LU0345769631.USD","LU0256863902.USD","LU1629891620.HKD","LU1363072403.SGD","LU0211326755.USD","LU2168564495.EUR","LU0348827113.USD","LU0320765646.SGD","IE00BJTD4N35.SGD","LU1794554557.SGD","KURE","LU0348784397.USD","LU0070302665.USD","LU0208291251.USD","SG9999002232.USD","IE00BHPRN162.USD","IE000M9KFDE8.USD","LU2236285917.USD","LU1119994496.HKD","IE00BZ1G4Q59.USD","IE000SO60NU8.SGD","BK4588","IE0034235303.USD","LU0187121727.USD","JPMO","LU1267930490.SGD","IE000WAW04H5.SGD","LU0942090050.USD","LU2476274720.SGD","BK4504","LU1116320737.USD","BK4533","BK4581","LU1366192091.USD","LU0251132253.USD","LU2417539215.USD","LU0348766576.USD","LU2381873111.SGD","IE0034235295.USD","LU0634319403.HKD","LU1145028129.USD","LU2746668974.SGD","LU2213496289.HKD","LU1974910355.USD","LU1551013425.SGD","LU2430703095.HKD","LU2756315318.SGD","LU1917777945.USD","IE00BK4W5L77.USD","IE00BFXG1179.USD","LU0345769128.USD","LU2746668461.USD","IYG","IE00BJTD4V19.USD","IE0034235188.USD","LU0640476718.USD","LU0211327993.USD","IE00BLSP4239.USD","LU2023250330.USD","LU1244550221.USD","LU0310799852.SGD","TFNS","LU2168564065.EUR","LU0203345920.USD","LU2756315664.SGD","IE000F7OJYX1.SGD","LU2778985437.USD","LU0417516738.SGD","LU0345770993.USD","IE00BK4W5M84.HKD","IE000MB6IJN5.SGD","LU0820561818.USD","LU1914381329.SGD","IE00B543WZ88.USD","LU0417516571.SGD","LU2430703251.USD","IE00BDRTCR15.USD","LU2592432038.USD","LU0345770308.USD","BK4207","LU1894683348.USD","LU1670628061.USD","LU0689472784.USD","BK4550","IE00BKVL7J92.USD","LU1244550577.SGD","LU0215105999.USD","LU2054465674.USD","LU2237443622.USD","IE00BBT3K403.USD","LU2237443382.USD","LU1162221912.USD","LU0964807845.USD","LU0211328371.USD","LU0540923850.HKD","LU1084165304.USD","LU2476274308.USD","LU0106261372.USD","IE00B5MMRT66.SGD","LU0868494708.USD","IE000BZT7R73.USD","LU0417517546.SGD","BK4534","IE00BN8TJ469.HKD","LU1366333091.USD","LU2237443978.SGD","BK4585","IXG","LU0348783233.USD","LU0348767384.USD","FTXO","LU0149725797.USD","LU0238689110.USD","LU0820561909.HKD","KBWB","LU0211331839.USD","LU2168564222.USD","LU2264538146.SGD","LU2399975544.HKD","LU2552382132.HKD","VFH","LU0256863811.USD","LU0203347892.USD","LU0976567544.SGD","LU0787776722.HKD","LU2023250504.SGD","BK4516","LU1670627923.USD","JPM","LU0859254822.USD","LU2357305700.SGD","IE00B1BXHZ80.USD","XLF","LU1032466523.USD","BK4566","LU0323591593.USD","IE00BKDWB100.SGD","BK1574","IYF","LU0157215616.USD","LU0820562030.AUD","LU1720051017.SGD","LU0868494617.USD","BK1161","LU1894683264.USD","LU0006306889.USD","LU0683600562.USD","LU0267386448.USD","LU2244417387.USD","LU0320765489.SGD","LU0943347566.SGD","IE00BYXW3230.USD","LU2552382058.USD","LU2168563687.JPY","LU0265550946.USD","LU1961090484.USD","LU0348735423.USD","LU2023250843.SGD","JPO","IE00B775SV38.USD","LU0265550359.USD","LU1551013342.USD","LU2168564149.EUR","LU2211815571.USD","LU1668664300.SGD","LU0106831901.USD","LU0496365809.HKD","IE0000B7K699.USD","LU1496350171.SGD","LU0234570918.USD","LU1280957306.USD","LU2505996681.GBP","IE00B3S45H60.SGD","LU1496350502.SGD","LU2357627491.SGD","LU1988902786.USD","LU0048584097.USD","IE00BLSP4452.SGD","FNCL","LU0234572021.USD","IE00BWXC8680.SGD","LU2237443895.HKD","LU2462157665.USD","LU2237443549.SGD","IE00BPRC5H50.USD","IE00B1XK9C88.USD","LU1548497426.USD","IE00BDCRKT87.USD","UYG","LU0882574139.USD","LU2505996509.AUD","LU1720050803.USD","LU2552382215.SGD","LU2430703178.SGD","LU0561508036.HKD","LU1261432733.SGD","LU1720051108.HKD","LU2106854487.HKD","LU0170899867.USD","SG9999002224.SGD","09926","LU0211326839.USD","LU2242649171.HKD","LU0417516902.SGD","LU0348825331.USD","LU1116320901.HKD","TRUF","IE00BJLML261.HKD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656927","title":"Big Pharma is Pouring Billions into China's Biotechs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656927","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656927?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:59","pubTimestamp":1789372740,"startTime":"0","endTime":"0","summary":"China's biotech industry has become as much a challenger to America's technological leadership as China's artificial intelligence upstarts.Big Pharma firms have cut license deals worth tens of billion","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","SG9999001176.SGD","LU0501845795.SGD","LU2097828557.USD","LU1781817850.SGD","LU2133065610.SGD","LU1699723380.USD","LU2476274720.SGD","BK1589","LU1894683264.USD","LU1032466523.USD","02269","LU0868494617.USD","LU0306806265.USD","GSKH","LU1585245621.USD","LU0516423091.SGD","LU1829250122.USD","LU0965509010.AUD","LU0130517989.USD","LU0052750758.USD","BK4534","LU0823416689.USD","BK4139","01276","LU2580892789.USD","LU1997245177.USD","IE00B2B36J28.USD","LU1969619763.USD","SGXZ57979304.SGD","BK4531","LU0140636845.USD","LU2097828631.EUR","IE00BZ08YR35.GBP","BK0028","LU0211331839.USD","LU0029874061.USD","LU1868836591.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","BK4599","OZEM","LU0856984785.SGD","LU3063872942.SGD","LU1997245094.SGD","LU0417516902.SGD","BK0183","BK1610","LU1242518931.SGD","LU0320765646.SGD","SG9999015358.SGD","IE0008368742.USD","BK4592","PPH","IE00BJT1NW94.SGD","LU2125154778.USD","BK1576","IXJ","LU0819121731.USD","BK0012","LU0072913022.USD","BK4550","IE00BLSP4239.USD","LU2488822045.USD","AZN","WXXWY","LU1718418525.SGD","LU0348766576.USD","LU1807302812.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK0188","BMED","BK4516","MRK","AZNH","LU1670710661.SGD","LU1093756325.SGD","LU0181495838.USD","LU1941712264.USD","LU2237443465.HKD","SG9999001176.USD","IE0008369823.USD","FTXH","SG9999003800.SGD","LU0859254822.USD","LU0128526141.USD","IE0002141913.USD","01177","LU0502904849.HKD","LU0588546209.SGD","LU1794554557.SGD","IHE","LU1328615791.USD","BMY","LU2433249047.HKD","LU2097828714.EUR","LU1323610961.USD","LU2361044865.SGD","LU1934455277.USD","LU0058720904.USD","LU1116320901.HKD","BK1141","LU0061475181.USD","LU1236620750.USD","BK0060","LU0456827905.SGD","LU0238689110.USD","LU2580892862.HKD","LU1670711123.USD","LU2361045086.USD","LU2456880835.USD","LU0128525929.USD","LU1917777945.USD","KURE","LU2237443622.USD","LU0114720955.EUR","LU0348783233.USD","LU0689626769.HKD","VHT","LU2237443895.HKD","LU1868836757.USD","ZLAB","LU0234572021.USD","LU1226287875.USD","LU2468319806.SGD","LU1983299246.USD","LU2097828805.USD","LU0225284248.USD","BK4526","LU0314109678.HKD","LU2357627491.SGD","LU1291159041.SGD","BK1574","RXL","BK4585","SG9999014567.USD","SG9999015341.SGD","PFE","LU0067412154.USD","SG9999002562.SGD","LU0098860793.USD","IE00BSNM7G36.USD","LU0477156953.USD","SG9999013999.USD","LU1997244956.HKD","LU1035773651.USD","JDOC","PAWZ","LU0432979614.USD","LU0109394709.USD","SG9999014559.SGD","LU0203347892.USD","LU1152091168.USD","SG9999014575.USD","LU1201861249.SGD","LU0130102774.USD","LU0327786744.USD","LU1069347547.HKD","LU0456855351.SGD","LU1226288170.HKD","BK4559","LU1989771016.USD","LU1074936037.SGD","LU0321505439.SGD","BK4581","LU1820825898.SGD","LU0237698245.USD","LU0310800379.SGD","LU2360032135.SGD","LU0985481810.HKD","LU2324357040.USD","01801","GSK","LU0540923850.HKD","LU0417516571.SGD","LU1883839398.USD","LU2242644610.SGD","IE00B19Z3B42.SGD","LU1188198961.HKD","LU1066053197.SGD","600276","LU0463099449.HKD","LU0405327494.USD","LU0106261372.USD","IE00BN8TJ469.HKD","LU1688375341.USD","LU2106854487.HKD","LU0348827113.USD","LU1923622614.USD","IE00B4R5TH58.HKD","LU2491050071.SGD","LU0359202008.SGD","FHLC","LU0289739699.SGD","LU0244354667.USD","LU1255011170.USD","IE00BFXG1179.USD","LU1960683339.HKD","LU0320765489.SGD","LU2023250504.SGD","LU1720050803.USD","SBHMY","IE00B5MMRT66.SGD","LU1894683348.USD","LU2289578879.USD","LU2491049909.HKD","LU1226287792.SGD","LU0708994859.HKD","LU2462157665.USD","LU0124676726.USD","LU0965508806.USD","LU1064131003.USD","LU2596442595.SGD","LU0942090050.USD","BK4533","LU0965509101.SGD","LU1066051225.USD","LU1929549753.HKD","LU0289739343.SGD","LU0320764599.SGD","LU0315179316.USD","LU1261432733.SGD","IE00B3T34201.USD","BK1191","SG9999001440.SGD","09926","LU0359201612.USD","LU1989772923.USD","09688","LU0029864427.USD","IE00BFTCPJ56.SGD","LU0069063385.USD","IE00BBT3K403.USD","LU0868494708.USD","LU1066051498.USD","LU2125154935.USD","LU1974910355.USD","LU1831875114.USD","LU0326950275.SGD","LU1941712348.USD","01093","LU1146622755.USD","LU1813983027.USD","LU0861579265.USD","LU1951186391.HKD","LU0170899867.USD","LU0265550946.USD","LU1868836914.USD","LU1093756168.USD","LU0225771236.USD","LU0321505868.SGD","LU0348767384.USD","LU0889565916.HKD","BK4532","LU0985320562.USD","BK1521","LU1993786604.SGD","GSK.UK","LU0572944931.SGD","BK0239","LU2125909593.SGD","LU0289961442.SGD","LU1328277881.USD","IE00B543WZ88.USD","LU0417516738.SGD","SG9999002463.SGD","LU0306807586.USD","LU0708995583.HKD","LU2148510915.USD","IE00B031HY20.USD","LU2361044949.HKD","LU2461242641.AUD","LU1242518857.USD","LU0634319403.HKD","SMMT","BK1583","LU2495084118.USD","BK1515","LU2476274308.USD","LU1037948541.HKD","LU1670710588.SGD","LU1226288253.USD","BK0196","LU0472753341.HKD","BK4548","IE0009355771.USD","HK0000165453.HKD","SG9999002224.SGD","LU2237443978.SGD","GDOC","LU1961090484.USD","SG9999014542.SGD","BK1161","LU0979878070.USD","LU0039217434.USD","LU1066051811.HKD","IE0002270589.USD","LU2491050154.USD","IE00BPRC5H50.USD","BK4568","LU0149534421.HKD","LU0511384066.AUD","LU0348784397.USD","LU1430594728.SGD","LU2237443382.USD","LU0823426480.USD","LU1152091754.HKD","LU1162221912.USD","LU0882574055.USD","LU0348825331.USD","LU0208291251.USD","LU1267930573.SGD","BK4588","LU1037948897.HKD","LU0057025933.USD","IE00B1BXHZ80.USD","LU1057294990.SGD","LU1061106388.HKD","LU1226287529.USD","LU0348735423.USD","LU1064130708.USD","LU0405327148.USD","LU2125909247.SGD","TRUH","LU1934455194.USD","LU1989772840.SGD","LU0265550359.USD","LU0006306889.USD","LU0516422366.SGD","LU1008478684.HKD","LU1236620834.HKD","IE00BLSP4452.SGD","IYH","LU2778985437.USD","LU2097828474.EUR","LU0456846285.SGD","LU0122379950.USD","LU0051755006.USD","LU1934455863.HKD","LU2237443549.SGD","LU2236285917.USD","LU0648001328.SGD","LU2328871848.SGD","SG9999002232.USD","LU2417539215.USD","LU2112291526.USD","LU1116320737.USD","LU1868837300.USD","LU0823426308.USD","LU0561508036.HKD","IE000M9KFDE8.USD","IE00BZ08YT58.USD","LU0267386448.USD","LU0043850808.USD","SG9999011175.SGD","XLV","LU2242646821.SGD","IE00B0JY6N72.USD","BK4007","LU1580142542.USD","LU0516422440.USD","LU0455707207.USD","LU0965509283.SGD","LU0096364046.USD","LU2242652126.USD","LU0266013472.USD","LU1670711040.USD","LU2023250843.SGD","LU0320765992.SGD","LU1868837136.USD","LU0516422952.EUR","LU1571399168.USD","LU0980610538.SGD","LU0880133367.SGD","LU2399975544.HKD","LU1655091616.SGD","LU2089984988.USD","HRTS","LU0203345920.USD","LU0307460666.USD","LU0516423174.USD","LU1880383366.USD","LU0070302665.USD","SG9999004220.SGD","LU0607220059.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656833","title":"Innovent's Enlarged Cash Holdings, Investment Fair Value Could Boost Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656833?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:40","pubTimestamp":1789371600,"startTime":"0","endTime":"0","summary":"0740 GMT - Innovent Biologics' enlarged cash holdings and investment fair-value gains could bolster its earnings over 2026-2028, say DBS Group Research analysts in a note. The Chinese biopharmaceutical company's fair value of its investments such as wealth products increased in 1H, while its total cash is expected to rise to 29 billion yuan in December 2028 from 20 billion yuan in December 2025, they say. DBS raises its annual interest income projections by 76% over 2026-2028. It also lifts its 2026-2028 earnings estimates by 6%-21%. DBS reiterates its buy rating and 144.00 Hong Kong dollar target price on the stock. Shares are up 3.4% at HK$96.75.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU0244354667.USD","LU2097828631.EUR","HK0000165453.HKD","LU2097828474.EUR","LU2097828805.USD","BK1589","LU2242644610.SGD","01801","LU2097828557.USD","LU0502904849.HKD","LU1831875114.USD","KURE","BK1161","LU0463099449.HKD","LU2097828714.EUR","LU1188198961.HKD","LU2328871848.SGD","LU0326950275.SGD","BK1583","LU0149534421.HKD","LU0455707207.USD","LU2488822045.USD","LU0607220059.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104674198","title":"Citi Highlights Akeso's HARMONi-2 Overall Survival Edge, Reaffirming Buy Rating on Differentiation","url":"https://stock-news.laohu8.com/highlight/detail?id=1104674198","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104674198?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:32","pubTimestamp":1789371143,"startTime":"0","endTime":"0","summary":"Citi has released a research report noting that the interim analysis from AKESO's (09926) HARMONi-2 trial demonstrates a meaningful overall survival benefit for ivonescimab as a first-line...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU0540923850.HKD","LU1791807156.HKD","LU0072461881.USD","LU2125154935.USD","LU2462157665.USD","LU1244550577.SGD","LU0648001328.SGD","LU1720050803.USD","IYF","LU2476274308.USD","09926","LU2488822045.USD","LU2476274720.SGD","BK4566","LU0203345920.USD","LU0348827113.USD","LU0561508036.HKD","LU2456880835.USD","LU1244550494.USD","LU0348825331.USD","LU0348767384.USD","LU2125154778.USD","LU2360032135.SGD","LU1794554557.SGD","LU1668664300.SGD","IE00B543WZ88.USD","LU0348783233.USD","LU0052756011.USD","IE00B5MMRT66.SGD","IE00BSNM7G36.USD","KURE","LU0128525689.USD","LU0417516902.SGD","LU2236285917.USD","BK4504","LU0348735423.USD","LU0106831901.USD","LU0203347892.USD","BK4559","LU0348784397.USD","LU0320765646.SGD","BK1161","LU1144417596.USD","TFNS","BK1574","LU1201861249.SGD","LU0417516571.SGD","BK4534","LU0130102774.USD","LU0634319403.HKD","LU0348766576.USD","BK4585","LU0098860793.USD","LU1267930227.SGD","BK4207","LU0417516738.SGD","LU2399975544.HKD","BK4588","LU1074936037.SGD","LU0314106906.USD","LU0477156953.USD","LU0170899867.USD","LU0130517989.USD","LU1366192091.USD","LU1961090484.USD","LU0162691827.USD","LU2417539215.USD","C","LU1506573853.SGD","LU1162221912.USD","IE00BPRC5H50.USD","LU2778985437.USD","FTXO","LU0310800965.SGD","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184182375","title":"HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=1184182375","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184182375?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:00","pubTimestamp":1789365620,"startTime":"0","endTime":"0","summary":"Shares of innovative drug companies in Hong Kong are trading broadly higher on Tuesday, fueled by bullish clinical data presented at a major oncology conference and renewed optimism around policy...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","LU0417516902.SGD","159992","BK1191","LU2097828474.EUR","BK1583","IBBQ","LU2476274308.USD","LU0607220059.USD","LU2097828631.EUR","BK1161","LNGR","01177","IE00BZ08YS42.EUR","LU2097828557.USD","LU2778985437.USD","LU0348783233.USD","LU1720050803.USD","06978","IE00BZ08YR35.GBP","09969","IE00BZ08YT58.USD","LU0348767384.USD","01801","BK1521","LU2097828714.EUR","LU0463099449.HKD","LU0244354667.USD","LU0348784397.USD","LU1969619763.USD","LU2488822045.USD","LU2242644610.SGD","01530","LU1831875114.USD","LU0417516571.SGD","BK1589","LU2476274720.SGD","BK4585","LU1188198961.HKD","BK1515","KURE","LU0634319403.HKD","LU2097828805.USD","LU0348735423.USD","LU0348766576.USD","LU2328871848.SGD","LU1794554557.SGD","LU0348825331.USD","KCAI","BK4588","LU0417516738.SGD","LU0326950275.SGD","HK0000165453.HKD","VXUS","LU0455707207.USD","MEDX","LU2399975544.HKD","IE00B543WZ88.USD","LU0502904849.HKD","BK1593","IE00B5MMRT66.SGD","LU0561508036.HKD","LU0149534421.HKD","BK1574","LU0540923850.HKD","IE00BPRC5H50.USD","LU1961090484.USD","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163734342","title":"Hong Kong Market Update | CRO Stocks Lead Gains as Interim Results Reinforce Sector Momentum, Multiple Firms Lift Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1163734342","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163734342?lang=en_us&edition=fundamental","pubTime":"2026-09-14 10:28","pubTimestamp":1789352894,"startTime":"0","endTime":"0","summary":"CRO concept stocks are leading the advances in Hong Kong trading, with Asymchem (06821) jumping 5.89% to HK$142.10, Pharmaron (03759) climbing 4.72% to HK$28.84, TigerMed (03347) rising 4.64% to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU0456846285.SGD","LU0417516738.SGD","LU0348825331.USD","LU0326950275.SGD","03347","LU0327786744.USD","LU0561508036.HKD","LU0708995583.HKD","KCAI","LU0516422366.SGD","LU0516422952.EUR","LU0043850808.USD","LU0823426480.USD","LU1688375341.USD","LU0516422440.USD","LU0417516902.SGD","VXUS","LU1880383366.USD","BK1521","LU0572944931.SGD","LU0181495838.USD","LU0307460666.USD","LU0979878070.USD","LU0856984785.SGD","BK1589","IE00B0JY6N72.USD","BK1576","LU0140636845.USD","BK1141","LU0029874061.USD","LU0320764599.SGD","BK4588","BK1610","LU0348827113.USD","LU0052750758.USD","03759","LU0456827905.SGD","BK4585","BK1191","LU0516423091.SGD","LU0348735423.USD","LU0823426308.USD","02269","LU0516423174.USD","LU0588546209.SGD","BK1583","LU3063872942.SGD","LU0819121731.USD","KURE","LU0359202008.SGD","06821","LU1720050803.USD","LU1794554557.SGD","LU0051755006.USD","SG9999002463.SGD","SG9999002562.SGD","LU0359201612.USD","LU2039709279.SGD","LU0128526141.USD","LU1242518857.USD","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135078998","title":"AKESO Shares Climb After WCLC Data Highlights OS Benefit of Lead Drug Versus Keytruda","url":"https://stock-news.laohu8.com/highlight/detail?id=1135078998","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135078998?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:51","pubTimestamp":1789350694,"startTime":"0","endTime":"0","summary":"AKESO (09926) shares opened more than 4% higher on Thursday, before paring gains to trade up 0.83% at HK$91.05, with turnover reaching HK$302 million.According to the company's official WeChat...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","LU1720050803.USD","BK1161","LU0348767384.USD","LU0348766576.USD","LU2399975544.HKD","LU0348784397.USD","BK1574","LU0417516902.SGD","LU0540923850.HKD","LU0417516571.SGD","IE00B543WZ88.USD","LU0348783233.USD","KURE","LU2476274308.USD","LU2488822045.USD","IE00B5MMRT66.SGD","LU2476274720.SGD","LU0417516738.SGD","LU1961090484.USD","LU0348825331.USD","LU0348735423.USD","LU1794554557.SGD","09926","LU0634319403.HKD","LU0348827113.USD","LU0561508036.HKD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183013396","title":"Goldman Sachs Sees Clear Recovery in China's CRO/CDMO Sector, Favorable on WuXi-Linked Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1183013396","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183013396?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:50","pubTimestamp":1789350635,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a research report indicating that the second quarter and first-half results this year reflect a clear recovery in China's CRO/CDMO industry, with companies exceeding...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","SG9999014674.SGD","LU2750360997.AUD","LU1794554557.SGD","LU0251131958.USD","LU1868836591.USD","LU1894683264.USD","LU0140636845.USD","LU0251142724.SGD","LU0516423174.USD","06821","LU0348735423.USD","LU2237443978.SGD","LU2237443465.HKD","LU0348825331.USD","LU0588546209.SGD","BK4516","LU0106831901.USD","LU0516422366.SGD","LU2471134796.USD","IE0034235188.USD","LU0572944931.SGD","LU1880383366.USD","SG9999002463.SGD","LU0210536198.USD","LU2237443895.HKD","LU2237443382.USD","IE0004091025.USD","LU1046422090.SGD","LU0456846285.SGD","LU2045819591.USD","IE00B19Z3B42.SGD","LU0327786744.USD","LU0823426480.USD","LU3063872942.SGD","LU1791807156.HKD","BK4552","LU1804176565.USD","IE00B19Z3581.USD","LU0469268626.HKD","LU0742534661.SGD","BK4504","BK4550","LU0979878070.USD","GSX","LU0128526141.USD","LU0819121731.USD","SG9999002562.SGD","LU0048573561.USD","LU0561508036.HKD","LU2471134952.CNY","LU2125910500.SGD","LU0039217434.USD","LU1688375341.USD","LU0868494708.USD","LU2750360641.GBP","LU0359201612.USD","LU1144417596.USD","BK1610","LU0052750758.USD","LU0516422952.EUR","LU0348766576.USD","IE00B0JY6N72.USD","LU1868837136.USD","IE0002270589.USD","LU1894683348.USD","BK4585","LU2242644610.SGD","02269","LU0348767384.USD","LU0326950275.SGD","BK1521","BK1141","02359","BK1589","LU2237443622.USD","IE00BFXG1179.USD","IE0004086264.USD","LU1868837300.USD","LU1242518857.USD","LU0516423091.SGD","LU2237443549.SGD","LU1242518931.SGD","LU0942090050.USD","LU0029874061.USD","LU1868836757.USD","BK4127","LU0417516738.SGD","LU0096364046.USD","LU1668664300.SGD","03759","BK4139","LU0417516902.SGD","IE00BSNM7G36.USD","LU2039709279.SGD","LU0320764599.SGD","LU0823426308.USD","LU0043850808.USD","BK4588","02268","BK1191","BK1576","CDMO","LU0708995583.HKD","LU2265009873.SGD","LU1720050803.USD","LU0181495838.USD","LU0051755006.USD","LU2488822045.USD","LU1868836914.USD","03347","BK4533","KURE","LU0061475181.USD","LU2471134523.USD","LU2471134879.HKD","LU0456827905.SGD","LU0868494617.USD","LU0345770993.USD","LU0359202008.SGD","LU0856984785.SGD","LU1188198961.HKD","BK1583","GS","LU2237438978.USD","LU0516422440.USD","LU2896262040.SGD","LU0345770308.USD","LU0244354667.USD","LU0348827113.USD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667891676","title":"Akeso Says Phase III HARMONi-2 Trial Shows Ivonescimab Lifts Overall Survival vs Pembrolizumab in PD-L1-Positive NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2667891676","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667891676?lang=en_us&edition=fundamental","pubTime":"2026-09-13 15:02","pubTimestamp":1789282963,"startTime":"0","endTime":"0","summary":"Akeso says Phase III HARMONi-2 trial shows ivonescimab lifts overall survival vs pembrolizumab in PD-L1-positive NSCLCAkeso disclosed positive overall survival results for ivonescimab versus pembroliz","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nNDL2GXnTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1961090484.USD","BK1574","IE00B5MMRT66.SGD","LU2476274308.USD","LU0348827113.USD","LU0348783233.USD","LU0348766576.USD","LU0561508036.HKD","LU2476274720.SGD","LU2399975544.HKD","LU2488822045.USD","IE00B543WZ88.USD","KURE","LU0348825331.USD","LU1720050803.USD","BK1161","LU0417516571.SGD","LU0348735423.USD","LU0348767384.USD","IE00BPRC5H50.USD","LU0417516738.SGD","09926","LU0634319403.HKD","LU0540923850.HKD","LU2778985437.USD","LU1794554557.SGD","LU0417516902.SGD","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115866351","title":"HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1115866351","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115866351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:13","pubTimestamp":1789096425,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks are experiencing sustained downward pressure in Hong Kong trading. As of the latest update, LEPU BIO (02157) has declined 3.91% to HK$38.05, while REMEGEN (09995) fell...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU2097828714.EUR","BK1191","BK1515","LNGR","09995","BK1574","LU1807302812.USD","IE00BZ08YS42.EUR","LU0149534421.HKD","LU1008478684.HKD","LU1226288253.USD","KURE","BK1589","LU2097828631.EUR","02157","MCRO","PEVC","IE00B543WZ88.USD","LU1226287792.SGD","LU1328277881.USD","LU1951186391.HKD","LU2039709279.SGD","BK1521","VXUS","LU0326950275.SGD","LU0463099449.HKD","LU1993786604.SGD","LU2097828474.EUR","LU0607220059.USD","LU2242644610.SGD","LU2488822045.USD","01093","LU1152091168.USD","HK0000165453.HKD","LU0244354667.USD","IE00BZ08YR35.GBP","LU2097828805.USD","LU0072913022.USD","06978","KCAI","LU1226287875.USD","LU0315179316.USD","LU1831875114.USD","BK1161","BK1583","LU1960683339.HKD","159992","IE00BZ08YT58.USD","MEDX","IE00B031HY20.USD","IE00B5MMRT66.SGD","BK4585","LU0140636845.USD","LU1226287529.USD","LU1226288170.HKD","LU0502904849.HKD","LU1188198961.HKD","LU0455707207.USD","LU1969619763.USD","LU0501845795.SGD","LU1813983027.USD","IE0008368742.USD","WRTH","LU2097828557.USD","LU2328871848.SGD","LU1152091754.HKD","LU0880133367.SGD","LU0314109678.HKD","LU0067412154.USD","BK4588","SG9999004220.SGD","IBBQ","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666195566","title":"Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666195566","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666195566?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:32","pubTimestamp":1789029120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 2.7% to 47.50 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 24954.47.This was the stock's second consecutive day of losses.Wuxi Biologics  Inc. closed 13% below its 52-week high of HK$54.45, which the company reached Aug. 26.Trading volume totaled 24.2 million shares, compared to the 50-day average of 37.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0819121731.USD","LU0516423091.SGD","LU0029874061.USD","LU0348735423.USD","LU0572944931.SGD","LU0359202008.SGD","LU0456846285.SGD","LU1720050803.USD","LU0708995583.HKD","LU0456827905.SGD","BK1576","LU0823426480.USD","LU0979878070.USD","SG9999002463.SGD","LU0588546209.SGD","LU0516423174.USD","LU0051755006.USD","LU0516422366.SGD","LU2039709279.SGD","KURE","SG9999002562.SGD","LU0417516902.SGD","LU0140636845.USD","LU0326950275.SGD","LU0823426308.USD","LU1880383366.USD","LU0320764599.SGD","IE00B0JY6N72.USD","LU0516422440.USD","LU1242518931.SGD","BK1521","LU1794554557.SGD","BK1589","BK1141","LU0307460666.USD","LU0417516738.SGD","LU0359201612.USD","LU0856984785.SGD","LU1242518857.USD","LU1688375341.USD","BK1610","LU0516422952.EUR","LU0327786744.USD","02269","LU0052750758.USD","LU3063872942.SGD","LU0348825331.USD","LU0128526141.USD","LU0039217434.USD","LU0043850808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566165","title":"CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666566165?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:30","pubTimestamp":1789029000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 3.6% to 8.77 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 24954.47.This was the stock's fourth consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 20% short of its 52-week high of HK$10.96, which the company reached Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 2.3%, SSY Group Ltd. fell 0.2%, and United Laboratories International Holdings Ltd. fell 3.9%.Trading volume totaled 150.3 million shares, compared to the 50-day average of 105.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","BK1191","IE00BZ08YS42.EUR","KURE","LU1008478684.HKD","LU1226288170.HKD","LU1226288253.USD","LU1226287792.SGD","LU0326950275.SGD","BK1515","IE00B5MMRT66.SGD","LU0140636845.USD","LU1813983027.USD","HK0000165453.HKD","LU0067412154.USD","LU2039709279.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","LU1152091168.USD","LU0880133367.SGD","LU0501845795.SGD","LU1152091754.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU0072913022.USD","LU1226287529.USD","LU0315179316.USD","LU1226287875.USD","IE0008368742.USD","LU1951186391.HKD","LU1960683339.HKD","LU0314109678.HKD","BK1521","LU1807302812.USD","01093","LU1328277881.USD","IE00B031HY20.USD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666991563","title":"Global Equities Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666991563","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666991563?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:22","pubTimestamp":1789024920,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day.0722 GMT - China Overseas Land & Investment could benefit from accelerating market consolidat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00688","BK1258","LU0819121731.USD","BK1229","LU0577902611.USD","IE00BHRH8C09.USD","SG9999013486.USD","SG9999003826.SGD","LU0823417653.USD","LU0251143029.SGD","BK1191","LU0689626769.HKD","SG9999000343.SGD","SG9999003800.SGD","LU0594300179.USD","LU0043850808.USD","LU1224709979.USD","SG9999005177.SGD","LU0588545730.USD","LU2226123227.USD","LU0140636845.USD","LU0345775950.USD","LU0650527681.SGD","LU0169518387.USD","LU1152091754.HKD","LU0898667661.SGD","SG9999009997.SGD","SG9999004220.SGD","LU0737861699.HKD","LU0011963245.USD","LU0029875118.USD","LU1282649810.SGD","BK4585","LU0173614495.USD","LU0314109678.HKD","LU1226288253.USD","LU0210637038.USD","LU0675040207.SGD","IE00B543WZ88.USD","LU2506952170.USD","ULVR.UK","LU0320764755.SGD","LU0315179316.USD","SGXZ51708014.SGD","LU0823397103.USD","LU0630378429.USD","LU1226288170.HKD","LU0543330483.HKD","LU0197773160.USD","LU0557290698.USD","IE0008368742.USD","IE0008369823.USD","LU0165289439.USD","LU0762540952.USD","LU0856984785.SGD","LU1226287529.USD","SGXZ24219693.SGD","IE00BHRH8D16.HKD","LU1634259557.SGD","SGXZ58947870.SGD","IE00BZ08YT58.USD","SG9999003925.USD","LU1807302812.USD","KURE","LU0737861269.HKD","IE00BVYPNP33.GBP","SG9999000459.SGD","SG9999010078.USD","LU0329678337.USD","SG9999001135.SGD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BG0RBZ43.SGD","LU3227948356.SGD","LU2506951958.HKD","BK1515","LU0329678170.USD","LU0532188223.SGD","SG9999001127.SGD","BK1555","LU0605514214.HKD","LU0048573645.USD","LU1328277881.USD","BK6516","LU0211331839.USD","LU0873338254.USD","LU0886674414.USD","LU0971096721.USD","LU1226287792.SGD","SG9999001846.SGD","LU0345776255.USD","LU0287142896.SGD","LU1960683339.HKD","IE00B031HY20.USD","LU0315178854.USD","LU0823413660.USD","LU0128522157.USD","LU1211504680.USD","SG9999001226.SGD","LU0061477393.USD","SGXZ91733576.SGD","LU0737861772.HKD","LU0096374516.USD","LU1813983027.USD","LU0878004406.USD","LU0950375773.USD","LU1130305938.SGD","LU1993786604.SGD","LU2237957811.SGD","LU0865486749.SGD","SGXZ43160589.SGD","LU0124676726.USD","LU1770036033.HKD","LU0326950275.SGD","LU0261945553.USD","SG9999002620.SGD","01997","BK1240","LU1956131251.USD","LU0577902454.USD","LU1008478684.HKD","LU1497733631.SGD","LU1497734951.SGD","LU1497733557.USD","LU0205439572.USD","BK1601","LU1282649067.USD","LU2152927971.USD","LU0882747503.HKD","BK4592","LU0261947096.USD","LU0326948709.USD","LU1363072403.SGD","LU2238330802.EUR","LU0488056044.USD","BK4183","LU0819123356.HKD","LU1282649141.HKD","LU2039709279.SGD","SG9999016042.SGD","CAOVY","LU1839390173.USD","LU0067412154.USD","LU0831093199.SGD","LU1316543674.SGD","LU1152091168.USD","SG9999007991.SGD","LU0229494975.USD","LU0235996351.USD","LU1951186391.HKD","LU0672654166.SGD","SG9999011175.SGD","IE00B5MMRT66.SGD","LU0955623706.USD","LU0441851309.USD","LU0955669360.SGD","LU0955648018.USD","SG9999006266.SGD","LU0648948544.HKD","LU0630378692.HKD","SG9999004360.SGD","IE00BKZH1Z71.USD","SG9999014484.SGD","LU0588545904.SGD","SG9999002679.SGD","IE0003895053.USD","LU1504937902.USD","UL","UN","LU0251144936.SGD","LU0823039010.USD","D05.SI","LU0384037296.USD","LU0501845795.SGD","SG9999013353.USD","03121","LU0084288322.USD","LU0192582467.USD","LU2226123490.SGD","SG9999002406.SGD","SGXZ16066938.SGD","BK1534","SG9999000475.SGD","LU0577902538.SGD","SG9999002604.SGD","LU0577902298.EUR","BK1521","LU0048597586.USD","LU0823417737.USD","SG9999013478.USD","LU0878005551.USD","LU0588545490.SGD","SG9999001903.USD","IE0031814969.USD","HK0000165453.HKD","IE00BGHQDM52.EUR","LU0441854154.USD","LU0577902371.SGD","SG9999002562.SGD","SG9999014302.SGD","BK6112","LU2257852520.SGD","BK6523","LU1226287875.USD","SGXZ27511609.SGD","LU0197773673.USD","LU0594300419.USD","01093","LU0072913022.USD","LU0831103253.SGD","LU1328615791.USD","SG9999002414.USD","SG9999008742.SGD","LU1634259391.SGD","LU0823413587.USD","SG9999009443.AUD","SG9999010052.SGD","LU0188438112.USD","LU0823038988.USD","LU0880133367.SGD","LU2506951875.HKD","LU2237957902.USD","LU0823397285.USD","BK4588","SG9999013460.SGD","LU1522347837.USD","SGXZ70427877.SGD","SG9999014492.USD","IE00BVYPNQ40.USD","LU2506952097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119404417","title":"Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1119404417","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119404417?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:26","pubTimestamp":1789021579,"startTime":"0","endTime":"0","summary":"Shares of CSPC PHARMA (01093) fell more than 4%, and at the time of writing, they were down 2.69% to HK$8.855, with a turnover of HK$938 million. CLSA issued a research note stating that the latest...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","LU1226287529.USD","LU1226287792.SGD","LU0315179316.USD","LU1813983027.USD","LU0880133367.SGD","KCAI","BK1191","LU1008478684.HKD","LU0072913022.USD","LU1152091754.HKD","LU1226287875.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","BK4585","LU0067412154.USD","LU1226288253.USD","LU1993786604.SGD","LU2039709279.SGD","KURE","LU1951186391.HKD","BK4588","VXUS","LU1807302812.USD","HK0000165453.HKD","LU0140636845.USD","IE00B031HY20.USD","LU0326950275.SGD","LU1328277881.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","BK1515","BK1521","IE0008369823.USD","IE0008368742.USD","LU1152091168.USD","SG9999004220.SGD","LU1960683339.HKD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU0314109678.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666987550","title":"CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666987550","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666987550?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:08","pubTimestamp":1789020480,"startTime":"0","endTime":"0","summary":"0608 GMT - CSPC Pharmaceutical's coming clinical data presentations over the next two months could serve as near-term share-price catalysts, say DBS Group Research's Mark Kong and Nico Chen in a note. The Chinese pharmaceutical group is scheduled to present on several key products, including Phase 3 clinical data for its GLP-1 fusion protein to treat obesity and diabetes, the analysts say. The company's voluntary participation is seen as a sign of confidence in the data, the analysts say. CSPC trades around 18X its 2027 price-to-earnings ratio, which is a roughly 28% discount to the peer average and offers an attractive entry point, they say. DBS reinstates its coverage of CSPC with a buy rating and 13.70 Hong Kong dollar target price. Shares fall 4.2% to HK$8.72.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","BK1191","LU1813983027.USD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0072913022.USD","LU0140636845.USD","LU0067412154.USD","LU1226287792.SGD","LU0326950275.SGD","LU1328277881.USD","IE00B031HY20.USD","BK1521","LU1226288253.USD","IE00BZ08YR35.GBP","IE0008368742.USD","LU1152091168.USD","LU1152091754.HKD","KURE","SG9999004220.SGD","LU1226287875.USD","LU1807302812.USD","HK0000165453.HKD","BK1515","LU0501845795.SGD","LU0314109678.HKD","LU0880133367.SGD","LU1951186391.HKD","01093","LU1226287529.USD","LU2039709279.SGD","LU0315179316.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536873","title":"WuXi Biologics Files HKEX Next-Day Disclosure, Share Capital Rises by 1.2 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536873","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536873?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:38","pubTimestamp":1788961137,"startTime":"0","endTime":"0","summary":"WuXi Biologics files HKEX next-day disclosure, share capital rises by 1.2 million sharesWuXi Biologics filed a next-day disclosure return on Sept. 9, 2026, reporting 1,200,000 new ordinary shares issu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL3Fk8Yw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0181495838.USD","LU3063872942.SGD","KURE","LU0348825331.USD","LU0307460666.USD","LU1794554557.SGD","LU0823426308.USD","SG9999002463.SGD","LU0039217434.USD","LU0516422366.SGD","LU1880383366.USD","LU1720050803.USD","LU1688375341.USD","LU0516422952.EUR","LU0819121731.USD","LU0348735423.USD","LU0043850808.USD","LU0417516738.SGD","BK1141","02269","LU0823426480.USD","BK1589","LU0326950275.SGD","LU0320764599.SGD","LU0572944931.SGD","LU0588546209.SGD","SG9999002562.SGD","BK1610","LU0516423091.SGD","LU2039709279.SGD","LU0708995583.HKD","LU0456846285.SGD","LU0359201612.USD","BK1576","LU1242518931.SGD","LU0128526141.USD","LU0856984785.SGD","LU1242518857.USD","IE00B0JY6N72.USD","LU0516423174.USD","LU0051755006.USD","LU0417516902.SGD","LU0516422440.USD","LU0327786744.USD","LU0029874061.USD","LU0140636845.USD","LU0456827905.SGD","LU0359202008.SGD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538664","title":"Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538664","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538664?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:03","pubTimestamp":1788955391,"startTime":"0","endTime":"0","summary":"Transcenta licenses HiCB bioprocessing technology to WuXi Biologics for RMB 10 million upfrontTranscenta entered a technology licensing and strategic collaboration agreement with WuXi Biologics coveri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLbxChqk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245177.USD","BK0196","SG9999006597.SGD","02269","LU0052750758.USD","LU0572944931.SGD","LU1242518857.USD","LU0140636845.USD","LU0128526141.USD","LU0516422366.SGD","KURE","LU1880383366.USD","LU0823413660.USD","LU2213484517.USD","LU0588546209.SGD","LU0043850808.USD","BK0187","BK1161","LU0307460666.USD","601939","LU0320764599.SGD","LU2039709279.SGD","LU0039217434.USD","SGXZ90724238.SGD","BK1610","BK0015","LU2289578879.USD","LU0181495838.USD","BK0183","SG9999001226.SGD","LU0456827905.SGD","LU0516423091.SGD","LU1997244956.HKD","LU0456846285.SGD","LU0823426308.USD","06628","IE00B0JY6N72.USD","BK1141","LU0417516738.SGD","LU0417516902.SGD","LU0823426480.USD","LU2148510915.USD","BK1521","LU1688375341.USD","LU0823397103.USD","LU1064130708.USD","LU0029874061.USD","LU0051755006.USD","LU1064131003.USD","SG9999002562.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538344","title":"Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538344?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955210,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8NNVMW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348825331.USD","BK1610","LU0588546209.SGD","LU0052750758.USD","LU1242518857.USD","LU0043850808.USD","LU0029874061.USD","02269","LU0823426480.USD","SG9999002562.SGD","LU0417516902.SGD","BK1576","LU0128526141.USD","LU0307460666.USD","LU0320764599.SGD","IE00B0JY6N72.USD","LU0348735423.USD","LU0516422366.SGD","BK1141","LU0819121731.USD","LU0039217434.USD","LU0051755006.USD","LU1688375341.USD","LU1880383366.USD","LU2039709279.SGD","BK1521","LU0140636845.USD","LU0516422440.USD","LU0516423091.SGD","LU0516423174.USD","LU0181495838.USD","LU0979878070.USD","LU0823426308.USD","BK1161","LU0456827905.SGD","06628","LU1794554557.SGD","LU1242518931.SGD","LU0359201612.USD","SG9999002463.SGD","LU0326950275.SGD","LU0856984785.SGD","LU0359202008.SGD","KURE","LU0456846285.SGD","LU0708995583.HKD","LU0516422952.EUR","LU0327786744.USD","LU1720050803.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666383175","title":"Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media","url":"https://stock-news.laohu8.com/highlight/detail?id=2666383175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666383175?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA8NNVMW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0979878070.USD","LU0359201612.USD","LU0359202008.SGD","LU0819121731.USD","LU1242518857.USD","LU0051755006.USD","LU0043850808.USD","LU0456827905.SGD","LU0326950275.SGD","LU0516422366.SGD","LU0516422440.USD","LU0823426480.USD","LU1794554557.SGD","LU0128526141.USD","BK1576","LU1880383366.USD","LU0320764599.SGD","LU0456846285.SGD","06628","LU2039709279.SGD","LU3063872942.SGD","LU0307460666.USD","BK1521","LU0417516902.SGD","LU0348735423.USD","BK1610","LU0516422952.EUR","LU1688375341.USD","IE00B0JY6N72.USD","LU0516423091.SGD","02269","LU0052750758.USD","LU0140636845.USD","LU0327786744.USD","LU0516423174.USD","LU0572944931.SGD","LU0856984785.SGD","LU1242518931.SGD","LU0588546209.SGD","LU0708995583.HKD","LU0348825331.USD","LU0823426308.USD","LU0417516738.SGD","LU0039217434.USD","BK1589","LU0029874061.USD","LU0181495838.USD","LU1720050803.USD","SG9999002562.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587876","title":"CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587876","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587876?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951640,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's (HKG:1093) SYH9102 injection obtained clinical trial approval from China's National Medical Products Administration.The clinical indication is for patients with solid tumors, according to a Wednesday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01093","LU1226287529.USD","LU1226287792.SGD","LU0315179316.USD","LU1813983027.USD","LU0880133367.SGD","BK1191","LU1008478684.HKD","LU0072913022.USD","LU1152091754.HKD","LU1226287875.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1226288253.USD","LU1993786604.SGD","LU2039709279.SGD","KURE","LU1951186391.HKD","LU1807302812.USD","HK0000165453.HKD","LU0140636845.USD","IE00B031HY20.USD","LU0326950275.SGD","LU1328277881.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","BK1515","BK1521","IE0008369823.USD","IE0008368742.USD","LU1152091168.USD","SG9999004220.SGD","LU1960683339.HKD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU0314109678.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}